Cumberland Pharmaceuticals Inc expected to post a loss of 7  cents a share - Earnings Preview

Cumberland Pharmaceuticals

08/05/2021 01:51

* Cumberland Pharmaceuticals Inc  CPIX.OQ   CPIX.O  is expected
to show a rise in quarterly revenue when it reports results on
May 11 .
* The Nashville, Tennessee-based company is expected to report 
 a 2.1% increase in revenue to $8.503 million from $8.33 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Cumberland
Pharmaceuticals Inc is for a loss of 7 cents per share. For the
same quarter last year, the company reported earnings of 1 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Cumberland
Pharmaceuticals Inc is $8.5​, about 68.7% above​ its last
closing price of $2.66. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.01       -0.01      0.01      Beat    200
 Sep. 30 2020  -0.07       -0.07      0.02      Beat    128.6
 Jun. 30 2020  0.03        0.03       0.08      Beat    166.7​
 Mar. 31 2020  0.02        0.02       0.01      Missed  -50
 Dec.          ​           0.01       0.09      Beat    800​
 31​ 2019​                                              
 Sep. 30 2019  0.11        0.11       0.01      Missed  -90.9​
 Jun. 30 2019  0.07        0.07       0.10      Beat    42.9
 Mar. 31 2019  -0.11       -0.11      0.11      Beat    200
 This summary was machine generated May 8 at 00:51 GMT.  All
figures in US dollars unless otherwise stated